Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Xiao-Jiao Huo"'
Autor:
Qi-Liang Mao-Ying, Annemieke Kavelaars, Karen Krukowski, Xiao-Jiao Huo, Wenjun Zhou, Theodore J Price, Charles Cleeland, Cobi J Heijnen
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e100701 (2014)
Chemotherapy-induced peripheral neuropathy (CIPN) characterized by loss of sensory sensitivity and pain in hands and feet is the major dose-limiting toxicity of many chemotherapeutics. At present, there are no FDA-approved treatments for CIPN. The an
Externí odkaz:
https://doaj.org/article/44e74bf2bc20480e95f8aa91a8084fec
Autor:
Robert Z. Orlowski, Donna M. Weber, Muzaffar H. Qazilbash, Qaiser Bashir, Sheeba K. Thomas, Xiao Jiao Huo, Ashley Morphey, Jasper Olsem, Elisabet M. Manasanch, Hans C. Lee, Lei Feng, Jatin J. Shah, Krina K. Patel
Supplementary Table from Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant Myeloma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ed6cb02ccbc6a13a84d5107d924ef0
https://doi.org/10.1158/1078-0432.22486829.v1
https://doi.org/10.1158/1078-0432.22486829.v1
Autor:
Robert Z. Orlowski, Donna M. Weber, Muzaffar H. Qazilbash, Qaiser Bashir, Sheeba K. Thomas, Xiao Jiao Huo, Ashley Morphey, Jasper Olsem, Elisabet M. Manasanch, Hans C. Lee, Lei Feng, Jatin J. Shah, Krina K. Patel
Supplementary Figure from Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant Myeloma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4269a2958a66f83c9ac43cb9e6c54fce
https://doi.org/10.1158/1078-0432.22486832.v1
https://doi.org/10.1158/1078-0432.22486832.v1
Autor:
Robert Z. Orlowski, Donna M. Weber, Muzaffar H. Qazilbash, Qaiser Bashir, Sheeba K. Thomas, Xiao Jiao Huo, Ashley Morphey, Jasper Olsem, Elisabet M. Manasanch, Hans C. Lee, Lei Feng, Jatin J. Shah, Krina K. Patel
Purpose:In this study, the addition of ixazomib to lenalidomide maintenance post-autologous stem cell transplant (ASCT) in 64 patients with newly diagnosed multiple myeloma was evaluated on the basis of the observed benefit of lenalidomide-only maint
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82e6aca06ff2da252e789d6fb49cd52e
https://doi.org/10.1158/1078-0432.c.6532400.v1
https://doi.org/10.1158/1078-0432.c.6532400.v1
Autor:
Geoffroy Laumet, Cobi J. Heijnen, Robert Dantzer, Xiao Jiao Huo, Annemieke Kavelaars, Edgar T. Walters, Alexis Bavencoffe, Jules D. Edralin
Publikováno v:
Pain
Understanding the mechanisms that drive transition from acute to chronic pain is essential to identify new therapeutic targets. The importance of endogenous resolution pathways acting as a "brake" to prevent development of chronic pain has been large
Autor:
Krina K. Patel, Jatin J. Shah, Lei Feng, Hans C. Lee, Elisabet M. Manasanch, Jasper Olsem, Ashley Morphey, Xiao Jiao Huo, Sheeba K. Thomas, Qaiser Bashir, Muzaffar H. Qazilbash, Donna M. Weber, Robert Z. Orlowski
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 28(7)
Purpose: In this study, the addition of ixazomib to lenalidomide maintenance post-autologous stem cell transplant (ASCT) in 64 patients with newly diagnosed multiple myeloma was evaluated on the basis of the observed benefit of lenalidomide-only main
Publikováno v:
Brain Behav Immun
Cancer and its treatment are associated with neurotoxic side effects, including cognitive dysfunction, altered functional connectivity in the brain and structural abnormalities in white matter. There is evidence that cancer and its treatment can acce
Autor:
Elisabet E. Manasanch, Donna M. Weber, Muzaffar H. Qazilbash, Robert Z. Orlowski, Krina K. Patel, Hans C. Lee, Qaiser Bashir, Jatin J. Shah, Sheeba K. Thomas, Ashley Morphey, Jasper B. Olsem, Xiao Jiao Huo, Lei Feng
Publikováno v:
Blood. 138:4774-4774
Backrground: Several randomized controlled clinical trials have demonstrated improved outcomes for newly diagnosed multiple myeloma (NDMM) patients who were treated with lenalidomide as maintenance therapy after autologous stem cell transplant (ASCT)
Autor:
Pooja Singhmar, Fang C Mei, Annemieke Kavelaars, Yan Li, Xiao Jiao Huo, Xiaodong Cheng, Patrick M. Dougherty, Cobi J. Heijnen
Publikováno v:
Pain. 159:884-893
Chemotherapy-induced peripheral neuropathy (CIPN) is a major side effect of cancer treatment that significantly compromises quality of life of cancer patients and survivors. Identification of targets for pharmacological intervention to prevent or rev
Publikováno v:
Acta Neuropathologica Communications
Acta Neuropathologica Communications, Vol 6, Iss 1, Pp 1-14 (2018)
Acta Neuropathologica Communications, Vol 6, Iss 1, Pp 1-14 (2018)
Chemotherapy-induced cognitive impairment (CICI) is a commonly reported neurotoxic side effect of chemotherapy, occurring in up to 75% cancer patients. CICI manifests as decrements in working memory, executive functioning, attention, and processing s